Filing Flows › Bruker (BRKR) › Q3 2026 › vs Q2 2026
Bruker (BRKR) Q3 2026 vs Q2 2026 (quarter over quarter)
Bruker's revenue rose $35.5M (+4%) from $838M in Q2 2026 to $874M in Q3 2026.
Bruker, Q3 2026: revenue $874M (+2% year over year), operating margin -10.4%, net loss $110M, operating cash flow $118M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $874M | $838M | $35.5M | +4% |
| Income tax benefit | $12.2M | −$14.2M | $26.4M | — |
| Net loss | $110M | $50.9M | $58.8M | +116% |
| Costs & expenses | $996M | $918M | $77.9M | +8% |
| Operating costs | $965M | $904M | $61.2M | +7% |
| Interest & other, net | $30.9M | −$28.6M | $59.5M | — |
| Cost of revenue | $445M | $422M | $22.2M | +5% |
| Research & development | $92.0M | $94.3M | −$2.3M | -2% |
| SG&A | $226M | $239M | −$12.4M | -5% |
| Other operating costs | $202M | $148M | $53.7M | +36% |
| Operating cash sources | $228M | −$26.5M | $254M | — |
| Depreciation & amortization | $54.1M | $58.0M | −$3.9M | -7% |
| Share-based compensation | $6.1M | $5.6M | $500K | +9% |
| Working capital & other | $168M | −$90.1M | $258M | — |
| Net loss absorbed | $110M | $50.9M | $58.8M | +116% |
| Operating cash flow | $118M | −$77.4M | $196M | — |
Questions
How much did Bruker's revenue grow quarter over quarter in Q3 2026?
Bruker's revenue rose $35.5M (+4%) from $838M in Q2 2026 to $874M in Q3 2026.